Influenza vaccination coverage at community pharmacies: Positioning, needs, expectations and involvement of community pharmacists in the Franche-Comte region

被引:4
作者
Kroemer, M. [1 ,2 ]
Clairet, A. L. [1 ,2 ]
Kabiche, K. [1 ]
Bendjama, A. [1 ]
Bertrand, X. [3 ,4 ]
Limat, S. [1 ,2 ]
Nerich, V. [1 ,2 ]
机构
[1] CHU Besancon, Pole Pharm, 3 Blvd Alexandre Fleming, F-25030 Besancon, France
[2] Univ Bourgogne Franche Comte, INSERM, UMR 1098, Interact Hote Greffon Tumeur Ingn Cellulaire & Ge, Besancon, France
[3] CHU Besancon, Serv Hyg Hosp, 3 Blvd Alexandre Fleming, F-25030 Besancon, France
[4] Univ Franche Comte, Lab Chronoenvironm, CNRS, UMR 6249, Besancon, France
来源
INFECTIOUS DISEASES NOW | 2021年 / 51卷 / 03期
关键词
Community pharmacist; Health; Patient care; Vaccination; IMPACT;
D O I
10.1016/j.medmal.2020.10.012
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Influenza vaccination coverage currently remains below the 75% recommended threshold by the World Health Organization. To correct this situation, experiments have been successively carried out in France to enable community pharmacists to vaccinate at-risk populations. In this context, a study was conducted with pharmacists from the French Franche-Comte region to evaluate their positioning, needs and expectations regarding influenza vaccination at community pharmacies. Materials and methods: A survey was created and sent to licensed pharmacists in March of 2018. This consisted of 4 parts: characteristics of the community pharmacy; positioning of the pharmacist regarding vaccinations carried out at the pharmacy; training needs and expectations; and willingness to implement vaccinations. Results: The participation rate in this survey was 32% (137/427). More than 90% of the pharmacists agreed that community pharmacies' assets were adequate for the implementation of these vaccinations (accessibility and availability), although 52% considered this complicated. Their main fears were reluctance from patients and conflicts of interest with other health professionals authorized to vaccinate (58%). The needs and expectations regarding pharmacy student training were essential for 94% of them as well as continuous training of practicing pharmacists (96%). The willingness of pharmacists to vaccinate stemmed from the fact that influenza vaccination coverage would increase for at-risk subjects (36%). Conclusion: This survey allowed us to assess the favorable positioning and the real interest of pharmacists from Franche-Comte regarding the influenza vaccination done at community pharmacies, given the proviso that they were given relevant training and allocated adequate resources. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:285 / 289
页数:5
相关论文
共 14 条
  • [1] [Anonymous], J OFFICIEL LUNION EU
  • [2] Anotlyme, 2018, RECOMMANDATION VACCI
  • [3] Bonnitrin I, 2015, VACCINE, V33, P1099
  • [4] Impact of pharmacist administration of influenza vaccines on uptake in Canada
    Buchan, Sarah A.
    Rosella, Laura C.
    Finkelstein, Michael
    Juurlink, David
    Isenor, Jennifer
    Marra, Fawziah
    Patel, Anik
    Russell, Margaret L.
    Quach, Susan
    Waite, Nancy
    Kwong, Jeffrey C.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (04) : E146 - E152
  • [5] Comboroure J. -C., 2014, Annales Pharmaceutiques Francaises, V72, P122, DOI 10.1016/j.pharma.2013.10.001
  • [6] Generalisation de la vaccination par les pharmaciens d'officine, OBJ CAMP VACC 2019 2
  • [7] Impact of a pharmacist immunizer on adult immunization rates
    Higginbotham, Suzanne
    Stewart, Autumn
    Pfalzgraf, Andrea
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2012, 52 (03) : 367 - 371
  • [8] Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis
    Isenor, J. E.
    Edwards, N. T.
    Alia, T. A.
    Slayter, K. L.
    MacDougall, D. M.
    McNeil, S. A.
    Bowles, S. K.
    [J]. VACCINE, 2016, 34 (47) : 5708 - 5723
  • [9] Kirkdale C. L., 2017, Annales Pharmaceutiques Francaises, V75, P9, DOI 10.1016/j.pharma.2016.08.006
  • [10] Luau L, 2019, MED MALADIES INFECT, V49, pS131